Intuitive Surgical (NASDAQ:ISRG) Given New $518.00 Price Target at BTIG Research

Intuitive Surgical (NASDAQ:ISRG) had its price objective boosted by equities researchers at BTIG Research from $494.00 to $518.00 in a research note issued to investors on Monday, Benzinga reports. The firm presently has a “buy” rating on the medical equipment provider’s stock. BTIG Research’s target price suggests a potential upside of 8.26% from the company’s current price.

Several other research analysts have also weighed in on ISRG. Citigroup boosted their price objective on shares of Intuitive Surgical from $512.00 to $560.00 and gave the stock a “buy” rating in a research note on Thursday, August 22nd. Barclays boosted their price target on Intuitive Surgical from $430.00 to $490.00 and gave the stock an “overweight” rating in a research report on Thursday, July 18th. Raymond James raised their price objective on Intuitive Surgical from $500.00 to $540.00 and gave the company an “outperform” rating in a research report on Monday. Morgan Stanley boosted their target price on Intuitive Surgical from $375.00 to $460.00 and gave the stock an “equal weight” rating in a report on Monday, July 15th. Finally, Royal Bank of Canada raised their price target on Intuitive Surgical from $515.00 to $525.00 and gave the company an “outperform” rating in a report on Tuesday, October 8th. Six investment analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. Based on data from MarketBeat, Intuitive Surgical has a consensus rating of “Moderate Buy” and an average price target of $467.55.

Intuitive Surgical Price Performance

NASDAQ ISRG opened at $478.47 on Monday. The firm has a market cap of $169.71 billion, a P/E ratio of 86.37, a P/E/G ratio of 5.40 and a beta of 1.39. The stock’s 50-day moving average is $481.94 and its 200-day moving average is $436.37. Intuitive Surgical has a one year low of $254.85 and a one year high of $496.48.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Thursday, July 18th. The medical equipment provider reported $1.78 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.54 by $0.24. Intuitive Surgical had a return on equity of 13.04% and a net margin of 27.65%. The business had revenue of $2.01 billion for the quarter, compared to analyst estimates of $1.97 billion. During the same quarter last year, the firm earned $1.18 EPS. Intuitive Surgical’s revenue for the quarter was up 14.5% compared to the same quarter last year. Equities analysts anticipate that Intuitive Surgical will post 5.22 EPS for the current year.

Insider Buying and Selling

In related news, insider Mark Brosius sold 2,115 shares of the stock in a transaction on Thursday, September 12th. The stock was sold at an average price of $491.91, for a total value of $1,040,389.65. Following the completion of the sale, the insider now directly owns 295 shares in the company, valued at $145,113.45. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. In other news, EVP Robert Desantis sold 1,413 shares of Intuitive Surgical stock in a transaction dated Friday, July 26th. The stock was sold at an average price of $438.60, for a total value of $619,741.80. Following the completion of the transaction, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at approximately $2,414,931.60. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Mark Brosius sold 2,115 shares of the company’s stock in a transaction dated Thursday, September 12th. The shares were sold at an average price of $491.91, for a total value of $1,040,389.65. Following the sale, the insider now owns 295 shares in the company, valued at approximately $145,113.45. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 53,120 shares of company stock worth $25,528,753 in the last ninety days. Company insiders own 0.90% of the company’s stock.

Institutional Investors Weigh In On Intuitive Surgical

Hedge funds have recently added to or reduced their stakes in the business. Creekmur Asset Management LLC boosted its position in shares of Intuitive Surgical by 200.0% during the 1st quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 42 shares in the last quarter. Ridgewood Investments LLC acquired a new stake in Intuitive Surgical in the second quarter valued at approximately $26,000. Delos Wealth Advisors LLC increased its holdings in shares of Intuitive Surgical by 380.0% during the first quarter. Delos Wealth Advisors LLC now owns 72 shares of the medical equipment provider’s stock valued at $29,000 after acquiring an additional 57 shares in the last quarter. LRI Investments LLC acquired a new position in shares of Intuitive Surgical during the first quarter worth approximately $30,000. Finally, LGT Financial Advisors LLC lifted its holdings in shares of Intuitive Surgical by 415.4% in the 2nd quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider’s stock worth $30,000 after purchasing an additional 54 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.